Consolidated Statement of Cash Flow (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Cash Flows from Operating Activities
Net Income	$ 3,730,497	$ 5,271,805
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	1,839,082	1,482,784
Loss (gain) on disposal of assets		4,294
Non-cash share-based compensation expense and stock awards	273,783	304,342
Changes in assets and liabilities:
Decrease (Increase) in accounts receivable	(923,095)	(3,314,197)
Decrease (Increase) in inventory	367,922	(1,601,691)
Decrease (Increase) in contract assets	(2,052,951)	(526,024)
Decrease (Increase) in prepaid expenses & other assets	172,468	196,359
Increase (Decrease) in accounts payable	3,360,686	1,288,002
Increase (Decrease) in accrued expenses	(23,221)	1,008,682
Increase (Decrease) in unearned revenue	(50,488)	(3,383,550)
Total adjustments	2,964,186	(4,540,999)
Net Cash Provided by Operating Activities	6,694,683	730,806
Cash Flows from Investing Activities
Cash paid for acquisition	(9,400,000)	(50,001)
Capital expenditures	(311,669)	(595,227)
Purchase of equity securities	(949,293)
Net Cash (Used in) Investing Activities	(10,660,962)	(645,228)
Cash Flows from Financing Activities
Payments on notes	(4,614,303)	(909,457)
Borrowings on notes	5,133,220
Payments on bank debt	(3,760,415)	(2,870,999)
Borrowings on bank debt	11,735,210	1,898,542
Share repurchase	(29,032)
Payments on finance lease		(11,203)
Net Cash Provided by (Used in) Financing Activities	8,464,680	(1,893,117)
Net Increase (decrease) in cash and cash equivalents	4,498,401	(1,807,539)
Cash and cash equivalents at beginning of period	2,232,499	5,057,626
Cash and cash equivalents at end of period	6,730,900	3,250,087
Supplemental disclosures of cash flow information
Interest paid	600,178	884,103
Income Taxes paid	1,175,300	1,507,700
Note Conversion		$ 648,000